Literature DB >> 2055083

Sleep apnea in patients with acute myocardial infarction.

T Saito1, T Yoshikawa, Y Sakamoto, K Tanaka, T Inoue, R Ogawa.   

Abstract

OBJECTIVE: To document sleep apnea in the acute phase of myocardial infarction. If apnea occurs in patients with myocardial infarction, hypoxemia induced by apnea might exaggerate insufficiency of oxygen supplied to the damaged myocardium.
DESIGN: Prospective controlled study.
SETTING: Critical care unit of a teaching hospital. PATIENTS: Forty-nine patients, average age 64 yrs (range 49 to 91).
MEASUREMENTS AND MAIN RESULTS: Patient measurements were recorded on a polygraph using an apnea-monitor, pulse oximeter, pulmonary artery pressure monitor, and an ECG. All of the patients observed showed frequent apneic episodes. The apnea was especially frequent when the cardiac index was low. Capillary oxygen saturation of less than 90% (suggesting systemic hypoxia) was observed in 21 patients concomitantly with apnea. Occasionally, arrhythmias followed these episodes (premature supraventricular contractions [n = 10], premature ventricular contraction [n = 4], and ventricular tachycardia [n = 2]).
CONCLUSIONS: This study suggests that sleep apnea is common in the setting of acute myocardial infarction. It may be a factor predisposing to, or even causing, sudden death in patients with acute phase of myocardial infarction.

Entities:  

Mesh:

Year:  1991        PMID: 2055083     DOI: 10.1097/00003246-199107000-00019

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  9 in total

1.  Sleep apnoea in ischaemic heart disease: differences between acute and chronic coronary syndromes.

Authors:  P Moruzzi; S Sarzi-Braga; M Rossi; M Contini
Journal:  Heart       Date:  1999-09       Impact factor: 5.994

2.  Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study.

Authors:  Daniel J Gottlieb; Gayane Yenokyan; Anne B Newman; George T O'Connor; Naresh M Punjabi; Stuart F Quan; Susan Redline; Helaine E Resnick; Elisa K Tong; Marie Diener-West; Eyal Shahar
Journal:  Circulation       Date:  2010-07-12       Impact factor: 29.690

3.  Nocturnal hypoxaemia after myocardial infarction.

Authors:  A T Wilson; K S Channer
Journal:  Br Heart J       Date:  1995-05

4.  Sleep disordered breathing in patients with acute coronary syndromes.

Authors:  Sophia E Schiza; Emmanuel Simantirakis; Izolde Bouloukaki; Charalampos Mermigkis; Eleftherios M Kallergis; Stauros Chrysostomakis; Dimitrios Arfanakis; Nikolaos Tzanakis; Panos Vardas; Nikolaos M Siafakas
Journal:  J Clin Sleep Med       Date:  2012-02-15       Impact factor: 4.062

5.  Association of incident cardiovascular disease with progression of sleep-disordered breathing.

Authors:  Hassan A Chami; Helaine E Resnick; Stuart F Quan; Daniel J Gottlieb
Journal:  Circulation       Date:  2011-03-14       Impact factor: 29.690

Review 6.  A Narrative Review of How Sleep-Related Breathing Disorders and Cardiovascular Diseases Are Linked: An Update for Advanced Practice Registered Nurses.

Authors:  Chooza Moon; Cynthia H Phelan; Diane R Lauver; Lisa C Bratzke
Journal:  Clin Nurse Spec       Date:  2016 Nov/Dec       Impact factor: 1.067

7.  ECG derived Cheyne-Stokes respiration and periodic breathing are associated with cardiorespiratory arrest in intensive care unit patients.

Authors:  Adelita Tinoco; David W Mortara; Xiao Hu; Cass Piper Sandoval; Michele M Pelter
Journal:  Heart Lung       Date:  2018-10-17       Impact factor: 2.210

8.  Influence of obstructive sleep apnoea on coronary artery disease in a Chinese population.

Authors:  Yufei Liu; Meitan Wang; Jinghui Shi
Journal:  J Int Med Res       Date:  2022-08       Impact factor: 1.573

9.  OSACS score-a new simple tool for identifying high risk for Obstructive Sleep Apnea Syndrome based on clinical parameters.

Authors:  Filip M Szymanski; Krzysztof J Filipiak; Anna E Platek; Anna Hrynkiewicz-Szymanska; Grzegorz Karpinski; Grzegorz Opolski
Journal:  Anatol J Cardiol       Date:  2014-01-10       Impact factor: 1.596

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.